Cimatron's shares are publicly traded on the NASDAQ exchange and the TASE under the symbol CIMT. For more information, please visit Cimatron's web site at: http://www.cimatron.com
Safe Harbor Statement
This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to Cimatron's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Cimatron's ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, market demand for Cimatron products and services, long sales cycles, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties related to Cimatron's business, refer to Cimatron's filings with the Securities and Exchange Commission. Cimatron cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.
CIMATRON LIMITED
CONSOLIDATED STATEMENTS OF INCOME
(US Dollars in thousands, except for per share data)
Three months ended Twelve months ended
December 31, December 31,
2011 2010 2011 2010
Total revenue 12,226 11,013 40,714 36,074
Total cost of revenue 1,477 1,634 5,383 5,876
Gross profit 10,749 9,379 35,331 30,198
Research and development expenses,
net 2,031 1,692 6,739 6,014
Selling, general and administrative
expenses 6,799 6,282 24,453 22,053
Operating income 1,919 1,405 4,139 2,131
Financial income (expenses), net (186) 43 (195) 97
Taxes on income (339) (401) (1,327) (657)
Other 3 1 (6) (6)
Net income 1,397 1,048 2,611 1,565
Less: Net (income) loss
attributable to the
noncontrolling interest 44 45 57 26
Net income attributable to
Cimatron's shareholders $ 1,441 $ 1,093 $ 2,668 $ 1,591
Net income per share -
basic and diluted $ 0.15 $ 0.12 $ 0.29 $ 0.18
Weighted average number of
shares outstanding
Basic EPS (in thousands) 9,300 8,959 9,252 9,000
Diluted EPS (in thousands) 9,315 8,983 9,292 9,000
